Five-year follow-up with low-dose tacrolimus in patients with myasthenia gravis.
Minami
Naoya
N
Department of Neurology, Hokkaido Medical Center, Sapporo, Japan.
Fujiki
Naoto
N
Doi
Shizuki
S
Shima
Koji
K
Niino
Masaaki
M
Kikuchi
Seiji
S
Sasaki
Hidenao
H
D000203:Activities of Daily Living; D000328:Adult; D004359:Drug Therapy, Combination; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D007166:Immunosuppressive Agents / Q000009:adverse effects / Q000627:therapeutic use*; D008297:Male; D008875:Middle Aged; D009157:Myasthenia Gravis / Q000175:diagnosis / Q000188:drug therapy* / Q000276:immunology; D011239:Prednisolone / Q000008:administration & dosage / Q000627:therapeutic use; D011950:Receptors, Cholinergic / Q000276:immunology; D016559:Tacrolimus / Q000009:adverse effects / Q000627:therapeutic use*
D007166:Immunosuppressive Agents; D011950:Receptors, Cholinergic; D011239:Prednisolone; D016559:Tacrolimus